Your session is about to expire
← Back to Search
Text Messaging Support for Post-Emergency Care Assistance Programs (LEAP Trial)
N/A
Recruiting
Led By Austin Kilaru, MD, MSHP
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days post-discharge from the emergency department
Awards & highlights
LEAP Trial Summary
This trial will test if sending texts to patients after hospital discharge helps them get enrolled in public benefits programs.
Who is the study for?
Adults over 18 living in Philadelphia, visiting Penn Medicine Emergency Departments without needing hospitalization. They must speak/read English, have Medicaid/Medicare or no insurance, be eligible for public benefits programs, and have a stable mobile phone number for at least three weeks.Check my eligibility
What is being tested?
The study is testing if text messages can help connect emergency department patients to public benefits by comparing the effectiveness of texts plus a flyer with just the flyer alone. The main measures are calls made to Benefits Data Trust and applications submitted.See study design
What are the potential side effects?
Since this trial involves text messaging interventions rather than medical treatments, there are no direct physical side effects expected from participating in this study.
LEAP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 days post-discharge from the emergency department
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days post-discharge from the emergency department
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Participant Connection to BDT
Secondary outcome measures
Number of Applications Submitted
LEAP Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants in the intervention arm will receive a summary flyer providing contact information for benefits enrollment navigators at BenePhilly and will be instructed that study personnel will contact them one-day post-discharge to help connect them to a BDT enrollment navigator to help them submit their applications for public benefits. At Day 1 post-discharge, participants in the intervention group will receive a text message to prompt them to call the BDT enrollment navigators to complete their applications for public benefits they screened for while in the ED. On Day 3, patients will receive a follow-up message to assess whether they have contacted BDT. Those participants who indicate they have not yet connected with BDT on Day 3 will receive reminder text messages at Day 7 and 14 post-discharge.
Group II: Active ControlActive Control1 Intervention
Participants in the control group will receive a summary flyer providing contact information for benefits enrollment navigators at BenePhilly, which includes a unique study phone line provided by Benefits Data Trust. Currently, the standard of care is for ED patients to receive no information about public benefits. Therefore, the flyer represents an augmentation of usual care for patients randomized to the control group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Text Messaging Intervention
2011
N/A
~690
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,005 Previous Clinical Trials
42,882,127 Total Patients Enrolled
1 Trials studying Social Determinants of Health
786 Patients Enrolled for Social Determinants of Health
Benefits Data TrustUNKNOWN
Austin Kilaru, MD, MSHPPrincipal InvestigatorPrincipal Investigator
1 Previous Clinical Trials
72 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I don't have a stable phone number for the next 3 weeks.I cannot speak or read English.I am 18 years old or older.I am experiencing severe distress, whether it's breathing difficulties, physical pain, or emotional stress.I have private health insurance or no health insurance.I have a stable mobile phone number for the next 3 weeks.I am not intoxicated, unconscious, or unable to respond to questions.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Active Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research initiative accepting new participants?
"According to information on clinicaltrials.gov, this particular experiment is not currently in need of participants; the trial was initially posted January 9th 2023 and edited most recently December 8th 2022. Nonetheless, there are 202 other studies actively recruiting patients right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger